Title : Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602.

Pub. Date : 2012 Sep

PMID : 22150117






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602. Lenalidomide major histocompatibility complex, class II, DR beta 1 Homo sapiens